This report studies the CRISPR And CRISPR-Associated (Cas) Genes market. Clustered regularly interspaced short palindromic repeats (CRISPR) are segments of prokaryotic DNA containing short repetitions of base sequences. Each repetition is followed by short segments of "spacer DNA" from previous exposures to a bacteriophage virus or plasmid. The CRISPR/Cas system is a prokaryotic immune system that confers resistance to foreign genetic elements such as those present within plasmids and phages, and provides a form of acquired immunity. CRISPR associated proteins (Cas) use the CRISPR spacers to recognize and cut these exogenous genetic elements in a manner analogous to RNA interference in eukaryotic organisms. CRISPRs are found in approximately 40% of sequenced bacterial genomes and 90% of sequenced archaea. Cas9 was the first nuclease discovered, followed by Cpf1, which was discovered in the CRISPR/Cpf1 system of Francisella novicida. Other such systems are thought to exist. CRISPR/Editas Medicinec2 from the bacterium Leptotrichia shahii is RNA-guided CRISPR system that targets RNA rather than DNA, and can either cleave single-stranded RNA targets or knock them down. By delivering the Cas9 nuclease complexed with a synthetic guide RNA (gRNA) into a cell, the cell's genome can be cut at a desired location, allowing existing genes to be removed and/or new ones added. The Cas9-gRNA complex corresponds with the CAS III crRNA complex in the above diagram. CRISPR/Cas genome editing techniques have many potential applications, including altering the germline of humans, animals, and food crops. The use of CRISPR Cas9-gRNA complex for genome editing was the AAAS's choice for breakthrough of the year in 2015. Bioethical concerns have been expressed about the prospect of using this nascent biotechnology for editing the human germline. According to our (Global Info Research) latest study, the global CRISPR And CRISPR-Associated Genes market size was valued at USD 1424.5 million in 2022 and is forecast to a readjusted size of USD 1794 million by 2029 with a CAGR of 3.3% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes. Thermo Fisher Scientific, Editas Medicine, Caribou Biosciences, CRISPR therapeutics and Intellia therapeutics, Inc. are the top 5 players of CRISPR and CRISPR-Associated (Cas) Genes, with about 63% market shares. CRISPR And CRISPR-Associated (Cas) Genes industry is relatively concentrated, manufacturers are mostly in the Europe and North America. Among them, North America region accounted for more than 45% of the total market of global CRISPR And CRISPR-Associated (Cas) Genes. This report is a detailed and comprehensive analysis for global CRISPR And CRISPR-Associated Genes market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided. Key Features: Global CRISPR And CRISPR-Associated Genes market size and forecasts, in consumption value ($ Million), 2018-2029 Global CRISPR And CRISPR-Associated Genes market size and forecasts by region and country, in consumption value ($ Million), 2018-2029 Global CRISPR And CRISPR-Associated Genes market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029 Global CRISPR And CRISPR-Associated Genes market shares of main players, in revenue ($ Million), 2018-2023 The Primary Objectives in This Report Are: To determine the size of the total market opportunity of global and key countries To assess the growth potential for CRISPR And CRISPR-Associated Genes To forecast future growth in each product and end-use market To assess competitive factors affecting the marketplace This report profiles key players in the global CRISPR And CRISPR-Associated Genes market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher Scientific, Editas Medicine, Caribou Biosciences, CRISPR therapeutics and Intellia therapeutics, Inc., etc. This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence. Market segmentation CRISPR And CRISPR-Associated Genes market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets. Market segment by Type Genome Editing Genetic Engineering GRNA Database/Gene Librar CRISPR Plasmid Human Stem Cells Genetically Modified Organisms/Crops Cell Line Engineering Market segment by Application Biotechnology Companies Pharmaceutical Companies Academic Institutes Research and Development Institutes Market segment by players, this report covers Thermo Fisher Scientific Editas Medicine Caribou Biosciences CRISPR therapeutics Intellia therapeutics, Inc. Cellectis Horizon Discovery Plc Sigma Aldrich Precision Biosciences Genscript Sangamo Biosciences Inc. Lonza Group Limited Integrated DNA Technologies New England Biolabs Origene Technologies Market segment by regions, regional analysis covers North America (United States, Canada, and Mexico) Europe (Germany, France, UK, Russia, Italy, and Rest of Europe) Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific) South America (Brazil, Argentina and Rest of South America) Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa) The content of the study subjects, includes a total of 13 chapters: Chapter 1, to describe CRISPR And CRISPR-Associated Genes product scope, market overview, market estimation caveats and base year. Chapter 2, to profile the top players of CRISPR And CRISPR-Associated Genes, with revenue, gross margin and global market share of CRISPR And CRISPR-Associated Genes from 2018 to 2023. Chapter 3, the CRISPR And CRISPR-Associated Genes competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast. Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029. Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and CRISPR And CRISPR-Associated Genes market forecast, by regions, type and application, with consumption value, from 2024 to 2029. Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War Chapter 12, the key raw materials and key suppliers, and industry chain of CRISPR And CRISPR-Associated Genes. Chapter 13, to describe CRISPR And CRISPR-Associated Genes research findings and conclusion.
1 Market Overview 1.1 Product Overview and Scope of CRISPR And CRISPR-Associated Genes 1.2 Market Estimation Caveats and Base Year 1.3 Classification of CRISPR And CRISPR-Associated Genes by Type 1.3.1 Overview: Global CRISPR And CRISPR-Associated Genes Market Size by Type: 2018 Versus 2022 Versus 2029 1.3.2 Global CRISPR And CRISPR-Associated Genes Consumption Value Ma
